Patents by Inventor Mark Dominic D'Angelo

Mark Dominic D'Angelo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10857319
    Abstract: Continuity of therapy associated with a respiratory treatment device may be measured. Information relating to therapy administered via the respiratory treatment device to a subject during a therapy session may be received. Based on the received information, a quantity of therapy interruption events that occurred during the therapy session may be determined. A continuity indicator may be determined based on the quantity of therapy interruption events that occurred during the therapy session. The continuity indicator is indicative of continuity of therapy associated with the respiratory treatment device during the therapy session.
    Type: Grant
    Filed: January 5, 2012
    Date of Patent: December 8, 2020
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Mark Dominic D'Angelo, Benjamin Irwin Shelly
  • Patent number: 10688262
    Abstract: A respiratory therapy device is configured, such that it switches from one therapy mode to another therapy mode. The mode parameters for the latter therapy mode are based on usage information gather during the former therapy mode.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: June 23, 2020
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Zachary Dean Paul, Mark Dominic D'Angelo
  • Patent number: 10286165
    Abstract: Systems and methods for providing respiratory therapy to a subject respond and/or adapt to the detection of an occurrence of a respiratory event. For example, the pressure level of a pressurized flow of breathable gas may be increased responsive to the occurrence of one or more apneas. Based on usage information spanning more than one therapy session, such as the tracked pressure levels, a starting pressure level for a pressurized flow of breathable gas for a subsequent therapy session is determined. The starting level at the beginning of the subsequent therapy session(s) may be the 90% pressure level as determined during the preceding period during which usage information has been gathered.
    Type: Grant
    Filed: March 26, 2013
    Date of Patent: May 14, 2019
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Gregory Delano Matthews, Benjamin Irwin Shelly, Heather Dawn Ressler, Michael Thomas Kane, Mark Dominic D'Angelo, Zachary Dean Paul
  • Publication number: 20150040903
    Abstract: Systems and methods for providing respiratory therapy to a subject respond and/or adapt to the detection of an occurrence of a respiratory event. For example, the pressure level of a pressurized flow of breathable gas may be increased responsive to the occurrence of one or more apneas. Based on usage information spanning more than one therapy session, such as the tracked pressure levels, a starting pressure level for a pressurized flow of breathable gas for a subsequent therapy session is determined. The starting level at the beginning of the subsequent therapy session(s) may be the 90% pressure level as determined during the preceding period during which usage information has been gathered.
    Type: Application
    Filed: March 26, 2013
    Publication date: February 12, 2015
    Inventors: Gregory Delano Matthews, Benjamin Irwin Shelly, Heather Dawn Ressler, Michael Thomas Kane, Mark Dominic D'Angelo, Zachary Dean Paul
  • Publication number: 20140102454
    Abstract: A respiratory therapy device is configured, such that it switches from one therapy mode to another therapy mode. The mode parameters for the latter therapy mode are based on usage information gather during the former therapy mode.
    Type: Application
    Filed: June 4, 2012
    Publication date: April 17, 2014
    Applicant: KONINKLIJKE PHILIPS N.V.
    Inventors: Zachary Dean Paul, Mark Dominic D'Angelo
  • Publication number: 20130340751
    Abstract: Continuity of therapy associated with a respiratory treatment device may be measured. Information relating to therapy administered via the respiratory treatment device to a subject during a therapy session may be received. Based on the received information, a quantity of therapy interruption events that occurred during the therapy session may be determined. A continuity indicator may be determined based on the quantity of therapy interruption events that occurred during the therapy session. The continuity indicator is indicative of continuity of therapy associated with the respiratory treatment device during the therapy session.
    Type: Application
    Filed: January 5, 2012
    Publication date: December 26, 2013
    Applicant: KONINKLIJKE PHILIPS N.V.
    Inventors: Mark Dominic D'Angelo, Benjamin Irwin Shelly